Essex Savings Bank Novo Nordisk A S Transaction History

Essex Savings Bank

$369 Million
Q1 2024

A detailed history of Essex Savings Bank transactions in Novo Nordisk A S stock. As of the latest transaction made, Essex Savings Bank holds 8,430 shares of NVO stock, worth $1.17 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

8,430

Previous 8,430 -0.0%

Holding current value

$1.17 Million

Previous $872,000 24.08%

% of portfolio

0.29%

Previous 0.25%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 22, 2024	BUY	$87.78 - $105.45 $83,039 - $99,755	946 Added 12.64%	8,430 $872,000
Q3 2023 Oct 12, 2023	BUY	$90.94 - $199.54 $340,661 - $747,476	3,746 Added 100.21%	7,484 $680,000
Q2 2023 Jul 19, 2023	BUY	$155.98 - $172.65 $2,027 - $2,244	13 Added 0.35%	3,738 $604,000
Q1 2023 Apr 24, 2023	BUY	$132.34 - $159.14 $4,234 - $5,092	32 Added 0.87%	3,725 $592,000
Q4 2022 Jan 18, 2023	BUY	$102.55 - $135.33 $615 - $811	6 Added 0.16%	3,693 $0

Q3 2022 Oct 19, 2022	SELL	$95.28 - $116.93 $38,588 - $47,356	-405 Reduced 9.9%	3,687 $367,000
Q2 2022 Jul 19, 2022	BUY	$103.24 - $121.81 $45,632 - $53,840	442 Added 12.11%	4,092 $456,000
Q2 2020 Jul 30, 2020	SELL	$58.54 - $67.94 $39,807 - $46,199	-680 Reduced 15.7%	3,650 $239,000
Q1 2020 Apr 28, 2020	SELL	$49.46 - $64.78 $1,632 - $2,137	-33 Reduced 0.76%	4,330 $261,000
Q3 2019 Oct 30, 2019	SELL	$47.54 - $53.43 $7,131 - $8,014	-150 Reduced 3.32%	4,363 $226,000
Q2 2019 Aug 09, 2019	SELL	$46.79 - $52.47 $1.49 Million - $1.67 Million	-31,756 Reduced 87.56%	4,513 $230,000
Q4 2018 Feb 01, 2019	BUY	$41.54 - $47.25 $1.51 Million - $1.71 Million	36,269 New	36,269 $1.67 Million

Others Institutions Holding NVO

# of Institutions

1,859

Shares Held

310M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $313B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Essex Savings Bank with notifications on news.

Account

Essex Savings Bank Novo Nordisk A S Transaction History